Carrabotta Marianna, MSc
September 2016: Master’s Degree in Cellular and Molecular Biology at the University of Catania (final grade: 110/110 cum laude)
October 2014: Bachelor’s Degree in Biology at the University of Catania (final grade: 102/110)
- From 01/11/2022 to present: PhD student at the
- Laboratory of Experimental Oncology, Rizzoli Orthopedics Institute (Bologna); PhD programme in Oncology, Hematology and Pathology, XXXVII cycle, University of Bologna. Project: “The role of PARP inhibitors in the cross-talk between DNA damage and activation of the cGAS/STING immune response signaling pathways in Ewing sarcoma cells”.
- From 11/05/2020 to present: 15 octies at the Istituto Ortopedico Rizzoli, Laboratorio di Oncologia Sperimentale. Project: “Efficacy assessment of new targeted combination therapies for muscoloskeletal sarcomas as the basis for tailoring patient’s treatments”.
- From 2018 to 2020 fellowship at the Istituto Ortopedico Rizzoli, Laboratorio di Oncologia Sperimentale. Project: “ITCCP4-Paediatric Preclinical Proof of Concept Platform- IMI2”.
- Internal student at the Department of Biomedical and Biotechnological Sciences, Medical Biochemistry Section, University of Catania. Project: “Second generation sequencing with <Ion Torrent> technology using PCR-Multiplex Custom panel on MSI colon rectal cancer samples”.
- Internal student at the Department of Biological, Geological and Environmental Sciences, section of Animal Biology, University of Catania. Project: “Toxicity test in Paracentrotus lividus: evaluation of the effects of some endocrine interferents”.
English: level C1, Ielts Certification (2017).
- Different laboratory techniques of cellular and molecular biology (cellular cells, MTT, PCR, DNA extraction, electrophoresis on gel, Wb; Immunofluorescence)
- Use of the Windows System and the Office Package (Word, Power Point, Excel)
- Use of data banks (NCBI, Pubmed, Gen Bank).
Obtaining primary cultures from patient-derived xenografts (PDX) obtained as a result of biopsy material from pediatric osteosarcoma and Ewing sarcoma tumors, and characterization of PDX models from a genetic and biological point of view.